Format

Send to

Choose Destination
Surgeon. 2009 Dec;7(6):345-50.

Primary peritonectomy/HIPEC for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures.

Author information

1
The University of New South Wales, Department of Surgery, St. George Hospital, Sydney, New South Wales, Australia.

Abstract

BACKGROUND:

Two main treatment options are available for pseudomyxoma peritonei (PMP) and disseminated peritoneal adenomucinosis (DPAM)--incomplete cytoreductive (debulking) surgery and peritonectomy with intraperitoneal chemotherapy. Several studies have demonstrated improved survival with peritonectomy. This study analyses outcome following peritonectomy in patients undergoing a primary procedure compared to those who have had previous debulks.

METHODS:

Between April 1997 and May 2008, 63 patients underwent peritonectomy for DPAM--38 had had previous debulk(s) and 25 underwent primary peritonectomy. Patients were followed-up at three- to six-monthly intervals postoperatively, with a mean follow-up time of 21 and 34 months, respectively.

RESULTS:

Mean survival for patients undergoing primary peritonectomy was 109.8 months. Mean survival for patients with previous debulks was 49.2 months (p=0.027). Five-year survival was 95.5% in the primary peritonectomy group and 67.5% in the previous debulk group.

CONCLUSION:

Disease recurrence after primary peritonectomy for DPAM is significantly less frequent than after secondary peritonectomy.

PMID:
20681377
DOI:
10.1016/s1479-666x(09)80108-x
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center